Accordingly, it may be proposed that a decrease in the SFRP1 protein expression and hypermethylation in the WIF-1 promoter region may increase the expression of Wnt ligands to enhance Wnt/ β-catenin in CCA. The gene discussed is SFRP1; the disease is cholangiocarcinoma.